Stock Predictions & Stock Market Forecast 2026, 2027, 2028, 2029, 2030
View analyst forecasts, price targets, buy/sell ratings, revenue/earnings forecasts and more

Ticker
Company
Zen Rating
Financials
Market Cap
ROE
ROA
ROCE
ROIC
D/E
Current Ratio
Gross Margin
Profit Margin
Operating Margin
FJDIU
ARC GROUP SECURITIES ACQUISITION I
N/AN/AN/AN/AN/A-2.76N/AN/AN/AN/A
IMC
IMC RARE EARTHS LTD
N/AN/AN/A70.91%N/A-2.000.41N/AN/AN/A
QMLS
QUMULUSAI INC
N/AN/AN/AN/AN/A6.892.24N/AN/AN/A
BIOT
INSTINCT BIO TECHNICAL CO INC
N/AN/AN/AN/AN/A0.412.19N/AN/AN/A
REF
REFORMATION INC
N/AN/AN/AN/AN/A1.091.58N/AN/AN/A
PLCI
PELICAN ACQUISITION II CORP
N/AN/AN/AN/AN/A-160.01N/AN/AN/AN/A
BRAI
BRAIIN LTD
N/AN/AN/A34.93%N/A-1.060.03N/AN/AN/A
PNAQ.U
PINNACLE ACQUISITION CORP
N/AN/AN/AN/AN/A-5.580.26N/AN/AN/A
VCRE
VICORE PHARMA HOLDING AB
N/AN/AN/AN/AN/A0.0912.69N/AN/AN/A
NUR
NURAN WIRELESS INC
N/AN/AN/AN/AN/A7.751.01N/AN/AN/A
CUVL
CLINUVEL PHARMACEUTICALS LTD
N/AN/AN/A20.80%N/A0.139.6881.20%37.80%54.14%
AZUL
AZUL SA
N/AN/AN/AN/AN/A-9.260.50N/AN/AN/A
LTGO
LATIGO BIOTHERAPEUTICS INC
N/AN/AN/AN/AN/A-0.063.23N/AN/AN/A
LYNX
LYNTRIS INC
N/AN/AN/AN/AN/A8.081.22N/AN/AN/A
XIIIU
CHURCHILL CAPITAL CORP XIII
N/AN/AN/AN/AN/A16.400.30N/AN/AN/A
ATTO
ATTOVIA THERAPEUTICS INC
N/AN/AN/AN/AN/A-0.1113.94N/AN/AN/A
SCTX
SCRIBE THERAPEUTICS INC
N/AN/AN/AN/AN/A-0.650.66N/AN/AN/A
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.